Cited by 2,055Gut microbiota and healthGastrointestinal motility and disordersMicrobial Metabolites in Food Biotechnology

Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome

Open access
Chassaing, Benoit, Koren, Omry, Goodrich, Julia K., Poole, Angela C., Srinivasan, Shanthi, Ley, Ruth E., Gewirtz, Andrew T.·2015·Nature

Abstract

The intestinal tract is inhabited by a large and diverse community of microbes collectively referred to as the gut microbiota. While the gut microbiota provides important benefits to its host, especially in metabolism and immune development, disturbance of the microbiota-host relationship is associated with numerous chronic inflammatory diseases, including inflammatory bowel disease and the group of obesity-associated diseases collectively referred to as metabolic syndrome. A primary means by which the intestine is protected from its microbiota is via multi-layered mucus structures that cover the intestinal surface, thereby allowing the vast majority of gut bacteria to be kept at a safe distance from epithelial cells that line the intestine. Thus, agents that disrupt mucus-bacterial interactions might have the potential to promote diseases associated with gut inflammation. Consequently, it has been hypothesized that emulsifiers, detergent-like molecules that are a ubiquitous component of processed foods and that can increase bacterial translocation across epithelia in vitro, might be promoting the increase in inflammatory bowel disease observed since the mid-twentieth century. Here we report that, in mice, relatively low concentrations of two commonly used emulsifiers, namely carboxymethylcellulose and polysorbate-80, induced low-grade inflammation and obesity/metabolic syndrome in wild-type hosts and promoted robust colitis in mice predisposed to this disorder. Emulsifier-induced metabolic syndrome was associated with microbiota encroachment, altered species composition and increased pro-inflammatory potential. Use of germ-free mice and faecal transplants indicated that such changes in microbiota were necessary and sufficient for both low-grade inflammation and metabolic syndrome. These results support the emerging concept that perturbed host-microbiota interactions resulting in low-grade inflammation can promote adiposity and its associated metabolic effects. Moreover, they suggest that the broad use of emulsifying agents might be contributing to an increased societal incidence of obesity/metabolic syndrome and other chronic inflammatory diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature14232

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Administration of two dietary emulsifiers, polysorbate-80 and carboxymethyl cellulose, induced obesity, intestinal inflammation, and metabolic dysfunction in mice in the absence of other dietary manipulations.

    “administration of two dietary emulsifiers, polysorbate-80 and carboxymethyl cellulose, induced obesity, intestinal inflammation, and metabolic dysfunction in the absence of other dietary manipulations in mice.”
  • The doses of emulsifiers used in the study are well within the amount consumed by humans.

    “the doses used in the study are well within the amount consumed by humans.”
  • The microbiota was both required and sufficient for these emulsifier-induced effects: germ-free mice were protected, and microbiota transfer from emulsifier-treated mice recapitulated the metabolic derangements.

    “The microbiota was both required and sufficient for these effects as GF mice were protected from detrimental consequences, and microbiota transfer from emulsifier-treated mice was sufficient to recapitulate the metabolic derangements (55).”
  • Emulsifiers and artificial sweeteners can promote metabolic syndrome features in mice by modulating the microbiota.

    “Emulsifiers and artificial sweeteners have been shown to be involved in the development of metabolic syndrome features through their modulation of the microbiota in mice46,47.”
  • Emulsifier feeding shifts gut microbiome composition, decreasing Bacteroidales and increasing mucolytic bacteria such as Ruminococcus gnavus.

    “The composition of the gut microbiome was also impacted with decreased abundances of the Bacteroidales (phylum: Bacteroidetes) and increased levels of mucolytic bacteria, such as Ruminococcus gnavus135.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chassaing, B., Koren, O., Goodrich, J. K., Poole, A. C., Srinivasan, S., Ley, R. E., & Gewirtz, A. T.
Affiliations
  • Bar-Ilan University (IL)
  • Cornell University (US)
  • Emory University (US)
  • Georgia State University (US)
Corresponding author
Gewirtz, Andrew T.
Venue
Nature
Published
2015-02-25
Volume
519
Issue
7541
Pages
92-96
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2134657806
Cited by
2,055
References
45
Citations by year
2026: 163 · 2025: 193 · 2024: 207 · 2023: 192 · 2022: 234 · 2021: 209 · 2020: 226 · 2019: 177 · 2018: 142 · 2017: 152 · 2016: 109 · 2015: 49
FWCI
65.35
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • Crohn's and Colitis Foundation (276509)
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (U24DK097153, DK083890, DK099071, R01DK099071, R01DK083890)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
Keywords
food emulsifiers, gut microbiota, colitis, metabolic syndrome, obesity, low-grade inflammation, carboxymethyl cellulose, Tween 80, inflammatory bowel disease, germ-free mice, fecal microbiota transplantation, food additives, adiposity, intestinal barrier integrity, pro-inflammatory bacteria
MeSH terms
Animals, Carboxymethylcellulose Sodium, Colitis, Diet, Feces, Female, Germ-Free Life, Inflammation, Intestinal Mucosa, Male, Obesity, Polysorbates, Metabolic Syndrome, Gastrointestinal Tract, Emulsifying Agents, Adiposity, Mice, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review